Mayur Uniquoters

US And European Exports And Diversified Sectors Will Drive Success

AnalystConsensusTarget

Not Invested

Based on Analyst Price Targets

Published

27 Jan 25

Updated

01 May 25

n/a

AnalystConsensusTarget's Fair Value

n/a

-22.0%

-1.3%

-22.0%

-1.3%

You can edit this narrative until May 12 6:00 AM. Then, changes will post as Updates.

Author's Valuation

₹742.534.2% undervalued

AnalystConsensusTarget Fair Value

Narrative

Updates8

Shared on 01 May 25

Fair value Decreased 7.65%

Shared on 23 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 17 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 02 Apr 25

Fair value Increased 3.14%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on 12 Mar 25

Fair value Increased 2.36%

AnalystConsensusTarget has decreased revenue growth from 11.4% to 9.1% and decreased future PE multiple from 27.3x to 24.6x.

AnalystConsensusTarget Fair Value

₹742.5

34.2% undervalued

Future estimation in

% p.a.

Decrease

Increase

Current revenue growth rate

9.62%

Chemicals revenue growth rate

0.62%

Risk Level (Discount Rate)

Our default considers factors like the company's size, volatility, profitablity and country of operation.

Decrease

Increase

Current discount rate

13.34%

Calculation

₹2.21b

Earnings '28

20.56x

PE Ratio '28

₹45.54b

Market Cap '28

₹45.54b

Market Cap '28

42.40m

No. shares '28

₹1.07k

Share Price '28

₹1.07k Share Price '28

Discounted to 2025 @ 13.45% p.a.

₹735.53

Fair Value '25